Parithera

Author: ceyu

August undefined, 2024

WebParithera’s goal is to save lives by providing a minimally invasive diagnostic which analyses cancer treatment resistance and allows clinicians to adjust treatment regimen. Activity or Research Description: Development of CTC liquid biopsy technologies with single cell … WebParithera aims to revolutionize cancer diagnosis. To help them bring their technology forward Biopôle chose to support the company with the Biopôle Start-up ...

Parithera - Overview, News & Competitors ZoomInfo.com

Web8 Dec 2024 · Parithera's latest funding round was a Loan for $0.11M on March 22, 2024. Date. Round. Amount. Investors. Valuation. Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. Revenue. Sources. 3/22/2024. Loan. $0.11M. ge parts wholesale

Parithera Company Profile: Valuation & Investors PitchBook

WebParithera is funded by École Polytechnique Fédérale de Lausanne. Funding Rounds. Edit Funding Rounds Section. Number of Funding Rounds 1. Total Funding Amount CHF100K. Parithera has raised a total of CHF100K in funding over 1 round. This was a Grant round raised on Nov 26, 2024. WebParithera Signals Growth Rate 0.80% Weekly Growth Weekly Growth 0.80%, 93rd % -35.5%. 530% Size Multiple 219x Median Size Multiple 219x, 100th %ile 0.00x 0.95x. 413Kx Key … WebIn this video Parithera shares a bit about who they are, how being part of Geneus helped their company and a birthday wish to Campus Biotech Innovation Park ... christi coburn

Early diagnosis of resistant cancer ETH Zurich

WebParithera enables accurate treatment decision guidance & monitoring from one simple blood draw An alternative to tissue biopsy is to study cells which detach from the solid … WebRegister and get more services Create your personal archive Get the Newsletter Set award alarms. Get involved ge parts trackingWebParithera is a company that operates in the Internet industry. It employs 21-50 people and has $1M-$5M of revenue. The company is headquartered in Switzerland. Read More. Headquarters: Switzerland. Website: www.parithera.com. Revenue: <$5 Million. Parithera's Social Media. Is this data correct? SIC Code 80,72. ge parts of a refrigerator door

"WebParithera Aug. 2024–Jan. 20246 Monate Epalinges, Vaud, Suisse The goal of this startup is to design a microfluidic device that allows a good … " - Parithera

Parithera

A FIT Tech Seed Loan of CHF 100k for MedTech startup …

WebParithera . Connect to CRM . Save . Summary Financials People Technology Signals & News Similar Companies. Highlights. Active Tech Count 17. About. Parithera is actively using 17 technologies for its website, according to BuiltWith. These include Viewport Meta, IPhone / Mobile Compatible, and SPF. WebParithera’s goal is to save lives by providing a minimally invasive diagnostic which analyses cancer treatment resistance and allows clinicians to adjust treatment regimen. Website...

Did you know?

Web21 Jan 2024 · Parithera, led by Dr. Antoine Herzog (CEO) and Dr. Weida Chen (CTO), both originally from ETH Zurich and now located at EPFL, provides a minimally invasive, inexpensive and highly actionable cancer diagnosis platform to … WebExplore Parithera's alternatives and competitors. Medicor Biosciences. Medicor Biosciences, founded in 2006 is a development-stage company focused on drug discovery for combating cancer.

Web22 Mar 2024 · Parithera aims at developing Circulating Tumor Cells (CTC) monitoring and liquid biopsies to better understand diagnostics and treatments follow-up for cancer … WebParithera SA. A medical device to detect cancer treatment resistance. Parithera’s goal is to save lives by providing a non-invasive diagnostic which analyses cancer treatment …

WebParithera Signals Growth Rate 0.80% Weekly Growth Weekly Growth 0.80%, 93rd % -35.5%. 530% Size Multiple 219x Median Size Multiple 219x, 100th %ile 0.00x 0.95x. 413Kx Key Data Points Twitter Followers 5.5k Similarweb Unique Visitors 15.0K Majestic Referring Domains 314 Parithera Investors (3) Web22 Mar 2024 · Parithera aims at developing Circulating Tumor Cells (CTC) monitoring and liquid biopsies to better understand diagnostics and treatments follow-up for cancer …

Web11 Apr 2024 · Cancer Therapy Evaluation Program study 9557 (ClinicalTrials.gov identifier NCT02097225) is a phase 1 study that was designed to assess the safety and efficacy of the small-molecule HSP90 inhibitor, AT13387, in combination with dabrafenib and trametinib in BRAF V600E/K –mutant solid tumors.

Web28 Jul 2024 · Parithera advances circulating tumour cells (CTCs) analysis for cancer diagnostics. Why CTCs? Antoine: By examining circulating tumour cells (CTCs), we get … ge parts shopWebParithera aims to revolutionize cancer diagnosis. To help them bring their technology forward Biopôle chose to support the company with the Biopôle Start-up ... christi clevelandWebWhat is it really like to work at Parithera? What do employees say about pay and career opportunities? Discover anonymous reviews now! christic manhoodWebParithera’s goal is to save lives by providing a minimally invasive diagnostic which analyses cancer treatment resistance and allows clinicians to adjust treatment regimen. Activity or … christi coffey fc tuckerWebParithera is the provider of a minimally invasive, inexpensive, and highly actionable cancer diagnosis platform to guide treatment decisions of clinicians. The company was founded in 2024 and is based in Epalinges, Switzerland. Headquarters Location Startlab, Bât. Alanine Route de la Corniche 5 Epalinges, 1066, Switzerland Suggest an edit ge part wh08x32657Webparithera. The Vision. Our Mission. The ExTrace. The Process. Partnerships. Careers. Contact. Scroll for more. Inquire. Please rotate your device in portrait mode for the best … christi cloydWeb2 Mar 2024 · Aiming to bring the first reliable diagnostics to detect cancer treatment resistance early, Parithera has created an innovative integrated platform that identifies circulating tumor cells (CTCs) that have detached from … christi clark realtor bellevue wa